Molecular Regulation of the RhoGAP GRAF3 and Its Capacity to Limit Blood Pressure In Vivo

Anti-hypertensive therapies are usually prescribed empirically and are often ineffective. Given the prevalence and deleterious outcomes of hypertension (HTN), improved strategies are needed. We reported that the Rho-GAP GRAF3 is selectively expressed in smooth muscle cells (SMC) and controls blood p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dee, Rachel A., Bai, Xue, Mack, Christopher P., Taylor, Joan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226614/
https://www.ncbi.nlm.nih.gov/pubmed/32331391
http://dx.doi.org/10.3390/cells9041042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226614/
https://www.ncbi.nlm.nih.gov/pubmed/32331391
http://dx.doi.org/10.3390/cells9041042

Ejemplares similares